Cell-Mediated Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 940
Special Issue Editors
Interests: epigenetics; drug delivery; MAPKs signaling; cancer
Special Issue Information
Dear Colleagues,
Developing novel therapeutics to combat diseases remains a major challenge. However, the systemic administration of drugs is often associated with several limitations, including poor bioavailability and a lack of target specificity. These factors typically require the use of higher dosages, which can lead to adverse side effects. The development of drug delivery systems enabling precise targeting and enhancing drug safety and efficacy is essential in overcoming these issues. In this regard, cell-based drug carriers are the ideal tools, due to their biocompatibility, low immunogenicity, prolonged circulation, and ability to reach virtually any body region. Moreover, they can be engineered to enable precise targeting.
This Special Issue will showcase the latest advancements in cell-based drug delivery systems and promote their further development. We encourage researchers to contribute by submitting original articles or reviews, to drive further progress in this important research field.
We look forward to receiving your contributions.
Dr. Monia Taranta
Dr. Lisa Gherardini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell-targeted drug delivery
- cell-mediated drug transport
- targeted therapy
- cellular uptake
- nanocarriers for drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
